Showing results (61-70 of 310) with videos related to
Sort By:
Pageof 31
Future Medicinal Chemistry|July 2, 2015
Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical applicationValentina Sepe, Eleonora Distrutti, Vittorio Limongelli, et al.Trends in Molecular Medicine|June 26, 2007
Targeting farnesoid X receptor for liver and metabolic disordersStefano Fiorucci, Gianni Rizzo, Annibale Donini, et al.World Journal of Gastroenterology|May 7, 2009
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculationBarbara Renga, Andrea Mencarelli, Marco Migliorati, et al.Plos One|May 22, 2013
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndromeEleonora Distrutti, Sabrina Cipriani, Andrea Mencarelli, et al.Expert Opinion on Investigational Drugs|June 20, 2020
Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)Stefano Fiorucci, Michele Biagioli, Valentina Sepe, et al.Molecular and Cellular Endocrinology|April 26, 2022
Immunomodulatory functions of FXRStefano Fiorucci, Angela Zampella, Patrizia Ricci, et al.Biochemical Pharmacology|June 27, 2009
The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel diseaseAndrea Mencarelli, Barbara Renga, Giuseppe Palladino, et al.Current Drug Targets. Immune, Endocrine and Metabolic Disorders|September 24, 2005
Role of FXR in regulating bile acid homeostasis and relevance for human diseasesGiovanni Rizzo, Barbara Renga, Andrea Mencarelli, et al.Journal of Molecular Graphics & Modelling|November 18, 2005
Unveiling hidden features of orphan nuclear receptors: the case of the small heterodimer partner (SHP)Antonio Macchiarulo, Giovanni Rizzo, Gabriele Costantino, et al.Trends in Immunology|March 4, 2026
Secondary bile acids as immune and metabolic mediatorsStefano Fiorucci, Michele Biagioli, Silvia Marchianò, et al.Pageof 31